Cardiovascular regulatory actions of the hypocretins in brain.

PubWeight™: 1.31‹?› | Rank: Top 10%

🔗 View Article (PMID 10412003)

Published in Brain Res on June 12, 1999

Authors

W K Samson1, B Gosnell, J K Chang, Z T Resch, T C Murphy

Author Affiliations

1: Department of Physiology, University of North Dakota School of Medicine, 501 North Columbia Road, Grand Forks, ND 58202-9037, USA. wsamson@mail.med.und.nodak.edu

Articles citing this

Elevated body temperature during sleep in orexin knockout mice. Am J Physiol Regul Integr Comp Physiol (2006) 1.71

The hypocretins/orexins: integrators of multiple physiological functions. Br J Pharmacol (2014) 1.42

Neuronostatin encoded by the somatostatin gene regulates neuronal, cardiovascular, and metabolic functions. J Biol Chem (2008) 1.19

Orexin, stress, and anxiety/panic states. Prog Brain Res (2012) 1.11

The brain hypocretins and their receptors: mediators of allostatic arousal. Curr Opin Pharmacol (2009) 1.03

Hypocretin/orexin in arousal and stress. Brain Res (2009) 1.03

Role of orexin in modulating arousal, feeding, and motivation. Front Behav Neurosci (2013) 1.01

The hypocretins are weak agonists at recombinant human orexin-1 and orexin-2 receptors. Br J Pharmacol (2000) 1.00

Effects of sleep on the cardiovascular and thermoregulatory systems: a possible role for hypocretins. J Appl Physiol (1985) (2010) 0.99

Respiration and autonomic regulation and orexin. Prog Brain Res (2012) 0.96

Attenuated heart rate response is associated with hypocretin deficiency in patients with narcolepsy. Sleep (2013) 0.93

Orexins induce increased excitability and synchronisation of rat sympathetic preganglionic neurones. J Physiol (2003) 0.93

Neuropeptides controlling energy balance: orexins and neuromedins. Handb Exp Pharmacol (2012) 0.90

Cellular mechanisms of orexin actions on paraventricular nucleus neurones in rat hypothalamus. J Physiol (2002) 0.89

Hypocretins and the neurobiology of sleep-wake mechanisms. Prog Brain Res (2012) 0.87

Orexin receptor subtype activation and locomotor behaviour in the rat. Acta Physiol (Oxf) (2009) 0.87

The hypocretin/orexin system. J R Soc Med (2002) 0.84

Orexin A and B evoke noradrenaline release from rat cerebrocortical slices. Br J Pharmacol (2001) 0.83

Orexin, orexin receptor antagonists and central cardiovascular control. Front Neurosci (2013) 0.81

The role of orexin-1 receptors in physiologic responses evoked by microinjection of PgE2 or muscimol into the medial preoptic area. Neurosci Lett (2011) 0.81

State-dependent control of lumbar motoneurons by the hypocretinergic system. Exp Neurol (2009) 0.80

Energy expenditure: role of orexin. Vitam Horm (2012) 0.79

The orexin-1 receptor antagonist SB-334867 decreases sympathetic responses to a moderate dose of methamphetamine and stress. Physiol Behav (2012) 0.79

The effect of orexin-A on cardiac dysfunction mediated by NADPH oxidase-derived superoxide anion in ventrolateral medulla. PLoS One (2013) 0.78

The role of the lateral hypothalamus and orexin in ingestive behavior: a model for the translation of past experience and sensed deficits into motivated behaviors. Front Syst Neurosci (2014) 0.78

Hypothalamic orexin's role in exacerbated cutaneous vasodilation responses to an anxiogenic stimulus in a surgical menopause model. Psychoneuroendocrinology (2015) 0.78

Understanding how discrete populations of hypothalamic neurons orchestrate complicated behavioral states. Front Syst Neurosci (2015) 0.77

The role of orexin in post-stroke inflammation, cognitive decline, and depression. Mol Brain (2015) 0.76

Dysautonomia in narcolepsy: evidence by questionnaire assessment. J Clin Neurol (2014) 0.76

A pivotal role for enhanced brainstem Orexin receptor 1 signaling in the central cannabinoid receptor 1-mediated pressor response in conscious rats. Brain Res (2015) 0.76

Orexinergic neurotransmission in temperature responses to methamphetamine and stress: mathematical modeling as a data assimilation approach. PLoS One (2015) 0.76

Cellular localization of orexins in human anterior pituitary. Histochem Cell Biol (2003) 0.76

Direct projections from hypothalamic orexin neurons to brainstem cardiac vagal neurons. Neuroscience (2016) 0.75

Thermoregulation under pressure: a role for orexin neurons. Temperature (Austin) (2015) 0.75

The evolving story of orexin biology: the hits keep coming. F1000 Biol Rep (2009) 0.75

Optogenetic identification of hypothalamic orexin neuron projections to paraventricular spinally projecting neurons. Am J Physiol Heart Circ Physiol (2017) 0.75

Implicating the potential role of orexin in hypertension. Naunyn Schmiedebergs Arch Pharmacol (2017) 0.75

Articles by these authors

Urinary excretion of histamine in renal transplant patients. Surg Gynecol Obstet (1968) 2.16

(D-Ala2)-Met-enkephalinamide: a potent, long-lasting synthetic pentapeptide analgesic. Science (1976) 1.95

Estrogen promotes growth of human thyroid tumor cells by different molecular mechanisms. J Clin Endocrinol Metab (2001) 1.52

Tanycytomas: a newly characterized hypothalamic-suprasellar and ventricular tumor. AJNR Am J Neuroradiol (2003) 1.45

Effects of meal ingestion on plasma amylin concentration in NIDDM and nondiabetic humans. Diabetes (1990) 1.41

A 35 amino acid fragment of leptin inhibits feeding in the rat. Endocrinology (1996) 1.38

Anti-proliferative effect of estrogen in breast cancer cells that re-express ERalpha is mediated by aberrant regulation of cell cycle genes. J Mol Endocrinol (2005) 1.29

Pressor effects of orexins injected intracisternally and to rostral ventrolateral medulla of anesthetized rats. Am J Physiol Regul Integr Comp Physiol (2000) 1.23

Endomorphin-1 mediates 2 Hz but not 100 Hz electroacupuncture analgesia in the rat. Neurosci Lett (1999) 1.19

Identification of multiple binding sites for atrial natriuretic factor by affinity cross-linking in cultured endothelial cells. J Biol Chem (1986) 1.15

Restricted ability of group B streptococcal C5a-ase to inactivate C5a prepared from different animal species. Infect Immun (1993) 1.15

Cells lacking CIP1/WAF1 genes exhibit preferential sensitivity to cisplatin and nitrogen mustard. Oncogene (1997) 1.12

Morphiceptin (NH4-tyr-pro-phe-pro-COHN2): a potent and specific agonist for morphine (mu) receptors. Science (1981) 1.11

Opiate receptor affinities and behavioral effects of enkephalin: structure-activity relationship of ten synthetic peptide analogues. Life Sci (1976) 1.10

Urinary histamine excretion in the rat following skin homografting and autografting. Ann Surg (1968) 1.03

Diuretic and antinatriuretic responses produced by the endogenous opioid-like peptide, nociceptin (orphanin FQ). Life Sci (1997) 1.03

Endomorphin and mu-opioid receptors in mouse brain mediate the analgesic effect induced by 2 Hz but not 100 Hz electroacupuncture stimulation. Neurosci Lett (2000) 1.01

Antibodies specific for alpha-N-acetyl-beta-endorphins: radioimmunoassays and detection of acetylated beta-endorphins in pituitary extracts. J Neurochem (1982) 1.00

Excitatory effects of human immunodeficiency virus 1 Tat on cultured rat cerebral cortical neurons. Neuroscience (2007) 1.00

Orexin A-like immunoreactivity in the rat brain. Neurosci Lett (1999) 1.00

Depressor and natriuretic activities of several atrial peptides. Regul Pept (1984) 0.98

Opiate and peptide interaction: effect of enkephalins on morphine analgesia. Eur J Pharmacol (1980) 0.98

Central administration of [Phe1psi(CH2-NH)Gly2]nociceptin(1-13)-NH2 and orphanin FQ/nociceptin (OFQ/N) produce similar cardiovascular and renal responses in conscious rats. J Pharmacol Exp Ther (1999) 0.98

Fumaric and sorbic acid as additives in broiler feed. Res Vet Sci (2007) 0.98

Immunoreactive dynorphin-(1-8) and corticotropin- releasing factor in subpopulation of hypothalamic neurons. Science (1983) 0.97

MR imaging of CNS tractopathy: wallerian and transneuronal degeneration. AJR Am J Roentgenol (1998) 0.97

IGF-I regulates osteoprotegerin (OPG) and receptor activator of nuclear factor-kappaB ligand in vitro and OPG in vivo. J Clin Endocrinol Metab (2002) 0.97

Central mechanisms for the hypertensive effects of preproadrenomedullin-derived peptides in conscious rats. Am J Physiol (1998) 0.95

Pulmonary vasodilation to adrenomedullin: a novel peptide in humans. Am J Physiol (1995) 0.94

Potent morphiceptin analogs: structure activity relationships and morphine-like activities. J Pharmacol Exp Ther (1983) 0.93

Postoperative 6-month and 1-year evaluation of health-related quality of life in total hip replacement patients. J Formos Med Assoc (2001) 0.93

Craniocervical junction venous anatomy on enhanced MR images: the suboccipital cavernous sinus. AJNR Am J Neuroradiol (1999) 0.93

Prolactin-releasing peptide-immunoreactivity in A1 and A2 noradrenergic neurons of the rat medulla. Brain Res (1999) 0.92

Neuronostatin is co-expressed with somatostatin and mobilizes calcium in cultured rat hypothalamic neurons. Neuroscience (2010) 0.92

In vitro potentiation of the activity of synthetic ovine corticotropin-releasing factor by arginine vasopressin. Peptides (1982) 0.92

Urotensin II-immunoreactivity in the brainstem and spinal cord of the rat. Neurosci Lett (2001) 0.90

Adrenomedullin dilates the pulmonary vascular bed in vivo. J Appl Physiol (1985) (1994) 0.90

Effects of nonsteroidal anti-inflammatory drugs and prostaglandins on osteoblastic functions. Biochem Pharmacol (1999) 0.90

Giant cervical epidural veins after craniectomy for head trauma. AJNR Am J Neuroradiol (1998) 0.90

A novel action of the newly described prolactin-releasing peptides: cardiovascular regulation. Brain Res (2000) 0.89

Ipsilateral fractures of the femoral neck and shaft. Injury (2000) 0.89

Activity-structure relationships of the thyrotropin releasing hormone. Biochem Biophys Res Commun (1970) 0.88

Dynorphin: a possible modulatory peptide on morphine or beta-endorphin analgesia in mouse. Eur J Pharmacol (1981) 0.88

Accidental penetrating cervical cord injury in a young child. Pediatr Emerg Care (1996) 0.87

Antiinflammatory drug effects on bone repair and remodeling in rabbits. Clin Orthop Relat Res (1995) 0.87

Prostate carcinoma cells that have resided in bone have an upregulated IGF-I axis. Prostate (2004) 0.87

Syntheses of pyroglutamylhistidylprolinamide and unusual mass fragmentation. J Med Chem (1971) 0.87

Mass treatment of head louse infestation with Sumithrin powder in primary schools in Korea. Kisaengchunghak Chapchi (1992) 0.87

Hypothalamic orexin A-immunoreactive neurons project to the rat dorsal medulla. Neurosci Lett (1999) 0.87

Accelerated release and production of orphanin FQ in brain of chronic morphine tolerant rats. Brain Res (1999) 0.87

Total solid-phase synthesis, purification, and characterization of human parathyroid hormone-(1-84). Biochemistry (1983) 0.86

Postoperative evaluation for disseminated medulloblastoma involving the spine: contrast-enhanced MR findings, CSF cytologic analysis, timing of disease occurrence, and patient outcomes. AJNR Am J Neuroradiol (2000) 0.86

Effects of ketorolac on bone repair: A radiographic study in modeled demineralized bone matrix grafted rabbits. Pharmacology (1998) 0.86

A synthetic human Agouti-related protein-(83-132)-NH2 fragment is a potent inhibitor of melanocortin receptor function. FEBS Lett (1998) 0.86

Identification of gastrin releasing peptide-related substances in guinea pig and rat brain. Biochem Biophys Res Commun (1983) 0.86

Physical functioning and health-related quality of life: before and after total hip replacement. Kaohsiung J Med Sci (2000) 0.86

Possible regulatory role of dynorphin on morphine- and beta-endorphin-induced analgesia. J Pharmacol Exp Ther (1981) 0.85

Caffeine consumption in patients with eating disorders. Hosp Community Psychiatry (1991) 0.85

Brain distributions of alpha-neo-endorphin and beta-neo-endorphin: evidence for regional processing differences. Biochem Biophys Res Commun (1982) 0.85

Orexins: a role in medullary sympathetic outflow. Regul Pept (2000) 0.85

Immunohistochemical localization of dynorphin (1-8) in hypothalamic magnocellular neurons: evidence for absence of proenkephalin. Life Sci (1983) 0.84

Synthesis of the luteinizing releasing hormone of the hypothalamus and its hormonal activity. Biochem Biophys Res Commun (1971) 0.84

Cardiovascular effects of peptides related to the enkephalins and beta-casomorphin. Life Sci (1980) 0.84

Amylin suppresses acetic acid-induced visceral pain and spinal c-fos expression in the mouse. Neuroscience (2009) 0.84

Serodiagnosis of cysticercosis by ELISA-inhibition test using monoclonal antibodies. Korean J Parasitol (1993) 0.83

Duplication of the extracranial internal carotid artery. AJNR Am J Neuroradiol (1995) 0.83

The effect of adrenomedullin on the isolated heart. Life Sci (1993) 0.83

Hypotensive action of synthetic fragments of parathyroid hormone. J Pharmacol Exp Ther (1981) 0.83

Blood pressure elevation in rats by peripheral administration of Tyr-Gly-Gly-Phe-Met-Arg-Phe and the invertebrate neuropeptide, Phe-Met-Arg-Phe-NH2. Life Sci (1982) 0.83

Gender-biased activity of the novel prolactin releasing peptides: comparison with thyrotropin releasing hormone reveals only pharmacologic effects. Endocrine (1998) 0.83

Core decompression for osteonecrosis of the femoral head at pre-collapse stage. Kaohsiung J Med Sci (2000) 0.83

Essential structural and functional determinants within the forkhead domain of FOXC1. Nucleic Acids Res (2004) 0.82

Dynorphin-(1-13): effects in nontolerant and morphine-dependent rhesus monkeys. Eur J Pharmacol (1982) 0.82

Changes in brain content of nociceptin/orphanin FQ and endomorphin 2 in a rat model of neuropathic pain. Neurosci Lett (2001) 0.82

An adrenomedullin fragment retains the systemic vasodepressor activity of rat adrenomedullin. Eur J Pharmacol (1994) 0.82

A dynorphin peptide induces hypotension by stimulating the release of atrial natriuretic peptide from rat atrium. Life Sci (1988) 0.82

The hypocretin/orexin story. Trends Endocrinol Metab (2000) 0.82

The actions of naloxazone on the binding and analgesic properties of morphiceptin (NH2Tyr-Pro-Phe-Pro-CONH2), a selective mu-receptor ligand. Life Sci (1981) 0.82

Adrenotensin: an ADM gene product with the opposite effects of ADM. Life Sci (1995) 0.82

Fully automated solid phase synthesis of protected peptide hydrazides on recycling hydroxymethyl resin. J Org Chem (1976) 0.81

The role of Chinese medicine in New York City's Chinatown. Am J Chin Med (Gard City N Y) (1976) 0.81

Nociceptin: an endogenous agonist for central opioid like1 (ORL1) receptors possesses systemic vasorelaxant properties. Life Sci (1997) 0.81

Unusual cardiac malformations in Holt-Oram syndrome: report of two cases. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi (1991) 0.81

[Identification and characterization of allergens of Chironomus flaviplumus adults (Chironomidae, Diptera) in mice]. Korean J Parasitol (1996) 0.81

Epidemiology of cervical and trochanteric fractures of the proximal femur in 1996 in Kaohsiung City, Taiwan. J Bone Miner Metab (2000) 0.81

Cocaine- and amphetamine-regulated transcript peptide-immunoreactivity in dorsal motor nucleus of the vagus neurons of immature rats. Brain Res Dev Brain Res (2001) 0.81

Dynorphin(1-10)amide: a potent and selective analog of dynorphin(1-13). Life Sci (1983) 0.81

Isolation of a specific mu-opiate receptor peptide, morphiceptin, from an enzymatic digest of milk proteins. J Biol Chem (1985) 0.81

Synthesis and relationship of L-glutaminyl-L-histidyl-L-prolinamide to the thyrotropin releasing hormone. Biochem Biophys Res Commun (1970) 0.80

Technetium-99m(V)-DMSA and gallium-67 in the assessment of bone and joint infection. J Nucl Med (1998) 0.80

Hip arthroplasty for osteonecrosis in patients with systemic lupus erythematosus. Kaohsiung J Med Sci (1999) 0.80

Endomorphin-like immunoreactivity in the rat dorsal horn and inhibition of substantia gelatinosa neurons in vitro. Neuroscience (1999) 0.80

Pituitary gland. Variable signal intensities on MRI. A pictorial essay. Clin Imaging (1998) 0.80

Dynorphin A-(1-10) amide stimulates the release of atrial natriuretic polypeptide (ANP) from rat atrium. Eur J Pharmacol (1987) 0.79

Synthesis of thymosin beta 4. Int J Pept Protein Res (1981) 0.79